Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD5991 (AZD-5991) | Mcl-1 inhibitor | Probechem Biochemicals
[MCL-1 Selective Inhibitors] AZD5991 (AZD-5991) [CT-A5991][CAS no ...
AZD5991 | Excenen PharmaTech
AZD5991 (an MCL-1 inhibitor) reduced Ba/F3-SPAG9-JAK2 cell viability A ...
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity ...
A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in ...
AZD5991 treatment increases Mcl-1 protein levels. (A) MOLM-13 and THP-1 ...
ERK1/2 pathway inhibitors combine with the MCL1 inhibitor AZD5991 to ...
(PDF) Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical ...
Action Mechanism of a Mcl-1 Inhibitor AZD5991 - Network of Cancer Research
AZD5991 resistance induction, siRNA knockdown, and IP of BIM show a ...
AZD5991 | Mcl-1 inhibitor | 2143061-81-6 | AdooQ®
AZD5991 induces intrinsic apoptosis in AML cells. (A) MOLM-13 and THP-1 ...
Results of Phase I study of MCL-1 inhibition with AZD5991 in R/R ...
Abstract PO2-14-10: A selective MCL-1 inhibitor AZD5991 showed tumor ...
AZD5991 | Bcl-2 inhibitor | CAS 2143010-83-5 | Selleck
c-Myc inhibition synergizes with AZD5991 in inducing apoptosis in AML ...
AZD5991 in combination with Venetoclax induces synergistic anti-MM ...
AZD5991 Alone or with Venetoclax - Multiple Myeloma Clinical Trials
c-Myc inhibition enhances AZD5991 antileukemic activity against AML ...
AZD5991 | 2143061-81-6 | Reference standards | Shimadzu Chemistry ...
Activity of AZD5991 and AZD59911CHOP in vivo. (A) BH3 profile of ...
c-Myc plays an important role in AZD5991 sensitivity. (A-D) Whole cell ...
AZD5991 can delay and overcome acquired resistance to BRAFi and/or ...
AZD5991 synergistically enhances apoptosis induced by gilteritinib and ...
Pre-clinical Formulation Development of an in situ Meglumine Salt of ...
Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based ...
AZD5991: A Potent Mcl-1 Inhibitor for Hematological Malignancies and ...
Combination of inhibitors of JNK (JNK-IN-8), MCL-1 (AZD5991), and ...
Structural Identification and Synthesis of the Acyl Glucuronide of the ...
AZD-5991 | Selective MCL-1 inhibitor | Antitumor | TargetMol
Multiscale Model Identifies Improved Schedule for Treatment of Acute ...
Co-crystal structures of MCL-1 in complex with its inhibitor. a ...
| Chemical structures of selective Mcl-1 inhibitors. The most prominent ...
Identification and validation of Mcl-1 as a AKT and PI3Kβ inhibitor ...
Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B ...
The combination of osimertinib with an Mcl-1 inhibitor augments the ...
(PDF) Multiscale Model Identifies Improved Schedule for Treatment of ...
Mcl-1 and AKT/PI3Kβ inhibitor combination rapidly induces apoptosis in ...
APG-1252-M1 in combination with an Mcl-1 inhibitor synergistically ...
Osteosarcoma cells are vulnerable to MAPK and MCL1 inhibition in vitro ...
BAK1 is a key mediator of Mcl-1 and PI3K/AKT inhibitor combination ...
c-Myc plays a critical role in the antileukemic activity of the Mcl-1 ...
Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity ...
Mcl-1 and AKT/PI3Kβ inhibitor combination activity in a panel of 44 ...
Apoptosis induced by combined ERK1/2 pathway and MCL1 inhibition ...
Anti-apoptotic MCL-1 promotes long-chain fatty acid oxidation through ...
Mcl-1 inhibition overcomes intrinsic and acquired regorafenib ...
Inhibition of Mcl1 synergistically enhances Gilteritinib and MRX2843 in ...
(PDF) Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and ...
(Ra)-7 induces on-target intrinsic apoptosis. a Apoptosis induction in ...
Mcl-1 and AKT/PI3Kβ inhibitor combination induces regression in ...
The rationale for combination therapy using MCL-1 inhibitors. Myeloid ...
RCSB PDB - 6FS0: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN ...
AbMole科研-抑制Mcl-1协同增强Gilteritinib和MRX-2843在FLT3突变AML临床前模型中的抗白血病活性 - 知乎
Mechanisms of MCL-1 protein stability induced by MCL-1 antagonists in B ...
Mcl-1/CDK9 Targeting By AZD5991/AZD4573 Overcomes Intrinsic and ...
ERK1/2 pathway inhibitors prime melanoma cells for rapid apoptosis ...
JCI Insight - Multidimensional, integrative profiling identifies BCL2L1 ...
Application of ReSCoSS to the macrocyle AZD5991. a ReSCoSS conformer ...
AZD-5991(AZD-5991) - 药物靶点：Mcl-1_专利_临床_研发
Multidimensional, integrative profiling identifies BCL2L1 methylation ...
c-Myc inhibition overcomes acquired resistance to AZD5991. (A) AML cell ...
